Inherited Retinal Disease Market Report 2026

Inherited Retinal Disease Market Overview

• Inherited Retinal Disease market size has reached to $12.54 billion in 2025 • Expected to grow to $18.62 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Rising Macular Degeneration Cases Boost Market Growth • Market Trend: Innovation In Mutation-Agnostic Gene Therapy Shaping The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Inherited Retinal Disease Market?

Inherited retinal diseases are a group of rare, genetic eye disorders caused by mutations in specific genes. These diseases primarily affect the retina, the thin layer of light-sensitive tissue at the back of the eye. They often present challenges for treatment due to their genetic complexity, but advancements in gene therapy and other innovative technologies offer promising solutions. The main types of treatment for inherited retinal disease are diagnosis, and therapy. Diagnosis involves the use of advanced technologies such as genetic testing, optical coherence tomography, and fundus imaging to identify inherited retinal diseases and their underlying genetic causes. These are used to treat various diseases such as retinitis pigmentosa, choroideremia, stargardt disease, cone-rode dystrophy, leber congenital amaurosis, and others and are distributed through various distribution channels such as retail sales, and direct tender, and used by various end users such as hospitals, specialty clinics, ambulatory surgical centers, home healthcare, and others.

What Is The Inherited Retinal Disease Market Growth Forecast?

The inherited retinal disease market size is expected to see strong growth in the next few years. It will grow to $18.62 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to advancements in gene therapy platforms, rising approvals of novel retinal therapies, increasing availability of genetic screening programs, expansion of precision medicine initiatives, growing investment in rare ophthalmic disease pipelines. Major trends in the forecast period include increasing adoption of genetic testing for early diagnosis, growing focus on gene and cell-based therapies, expansion of personalized treatment approaches, rising clinical trials for rare retinal disorders, improved patient access to advanced retinal imaging.

Global Inherited Retinal Disease Market Segmentation

1) By Type: Diagnosis, Therapy 2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rod Dystrophy, Leber Congenital Amaurosis, Other Diseases 3) By Distribution Channel: Retail Sales, Direct Tender 4) By End User: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users Subsegments: 1) By Diagnosis: Genetic Testing, Retinal Imaging, Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging 2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy, Photoreceptor Rescue Therapy

What Is The Driver Of The Inherited Retinal Disease Market?

The increasing prevalence of macular degeneration is expected to propel the growth of the inherited retinal disease market going forward. Macular degeneration is an age-related eye condition that damages the macula, leading to central vision loss and difficulty in activities such as reading or recognizing faces. The increasing prevalence of macular degeneration is driven by aging populations, higher life expectancy, and lifestyle factors such as smoking and poor nutrition, which elevate risk. Inherited retinal disease treatment helps macular degeneration patients by targeting the underlying genetic causes of retinal degeneration, providing therapies that slow disease progression, restore lost vision, or even prevent further damage to the retina, ultimately improving visual outcomes and quality of life for individuals affected by age-related or inherited forms of macular degeneration. For instance, in February 2024, according to the Canadian Ophthalmological Society, a Canada-based nonprofit organization, reported that 2.5 million people in Canada aged over 55 lose their vision due to age-related macular degeneration (AMD). Therefore, the increasing prevalence of macular degeneration is driving the growth of the inherited retinal disease industry.

Key Players In The Global Inherited Retinal Disease Market

Major companies operating in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics

Global Inherited Retinal Disease Market Trends and Insights

Major companies operating in the inherited retinal diseases market focus on developing innovative therapies, such as mutation-agnostic gene therapy, to provide inclusive treatment options and address a wider range of genetic variations associated with these conditions. Mutation-agnostic gene therapy is a treatment approach targeting broader genetic mechanisms or pathways, rather than specific mutations, making it applicable to diverse genetic disorders. For instance, in March 2024, Nanoscope Therapeutics Inc, a US-based biotechnology company, announced positive results of a clinical trial of its lead program, MCO-010, which demonstrates vision improvements for patients with permanent and severe vision loss from advanced retinitis pigmentosa. MCO-010 achieved its primary and key secondary endpoints with statistical significance and no serious adverse events.

What Are Latest Mergers And Acquisitions In The Inherited Retinal Disease Market?

In October 2024, Ocuphire Pharma, Inc. a US based biopharmaceutical company acquired Opus Genetics Inc. for an undisclosed amount. With this acquisition, Ocuphire Pharma, Inc. aims to strengthen its gene therapy portfolio and accelerate the development of innovative treatments for inherited retinal diseases (IRDs) by integrating Opus Genetics Inc.'s cutting-edge gene therapies targeting rare retinal conditions. Opus Genetics Inc. is a US based clinical stage gene therapy company focused on inherited retinal diseases.

Regional Outlook

North America was the largest region in the inherited retinal disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Inherited Retinal Disease Market?

The inherited retinal disease market includes revenues earned by entities by providing services such as ophthalmic tests, optic nerve imaging, and electrophysiological tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Inherited Retinal Disease Market Report 2026?

The inherited retinal disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the inherited retinal disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.